Trump tasks FDA to crack down on misleading drug advertising
The FDA says it has become slack in drug ad enforcement, intensified by social media.
Business & Regulation
Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens
Bavarian Nordic boosts 2025 guidance as takeover offer looms
CSL slashes 15% of workforce and offshoots vaccine division
Eli Lilly accused of bribing providers to prescribe GLP-1RA drugs
Podcast: US tariff news and Q2 earnings influence pharma trends
Mounjaro and Zepbound fuel strong Q2 growth for Eli Lilly
Why Liverpool’s Wirtz is causing concern at big pharma company Bayer
